Telmisartan-Teva (telmisartan) tablets 80 mg. №28

Description

Telmisartan-Teva (telmisartan) tablets 80 mg. №28

Composition

active substance: telmisartan;

1 tablet contains telmisartan 80 mg;

Excipients: sodium hydroxide, hypromellose, sorbitol (E 420), povidone, meglumine, mannitol

(E 421), magnesium stearate.

Dosage form

Tablets.

Main physical and chemical properties: white or almost white oblong tablets with a fracture line on one side.

Pharmacotherapeutic group

Simple drugs of angiotensin II receptor antagonists.
ATX code C09C A07.

Pharmacological properties

Telmisartan-Teva  is an antihypertensive drug that is used for therapy in essential hypertension. The maximum positive effect is observed after 1-2 months of treatment. The antihypertensive effect after taking the drug lasts for a day. Telmisartan-Teva lowers blood pressure within 3 hours after administration, without changing the heart rate.

Indications

Telmisartan-Teva is intended for use in the case of essential hypertension in adult patients, and for the prevention of cardiovascular diseases in patients with type II diabetes mellitus, as well as with obvious manifestations of atherothrombotic cardiovascular disease (peripheral arterial disease or stroke, coronary artery disease). hearts).

Contraindications

The drug is contraindicated for use in severe liver dysfunction, bile duct diseases and hypersensitivity to substances that are part of the tablets. Simultaneous administration with aliskiren is contraindicated in patients with impaired renal function or diabetes mellitus and do not prescribe the drug to children under 18 years of age.

Application during pregnancy and lactation

The drug is contraindicated for pregnant, lactating and planning pregnancy women.

Method of administration and dosage

Telmisartan-Teva tablets must be taken regardless of food, drinking plenty of fluids.
The recommended daily dose of Telmisartan-Teva is 40 mg. For some patients, a dose of 20 mg once a day is possible. If blood pressure is not sufficiently reduced at this dosage, then it can be increased to 80 mg per day.
Telmisartan-Teva can be taken in combination with other antihypertensive drugs.
The most effective antihypertensive effect is achieved after 1-2 months of treatment.
In the prevention of cardiovascular diseases, the recommended dose is 80 mg 1 time per 24 hours.
The maximum allowable dose is 80 mg per day.

Overdose

Symptoms in case of an overdose with Telmisartan-Teva may be: arterial hypotension, fainting, tachycardia, increased serum creatinine, bradycardia, acute renal failure. In case of intoxication, it is necessary to take activated charcoal, further treatment depends on the elapsed time after taking the drug and on the severity of the character and symptoms. The drug is not excreted by hemodialysis.

Side effects

The use of the drug can cause many adverse reactions such as: upper respiratory tract and urinary tract infections, sepsis, including death, anemia, eosinophilia and thrombocytopenia, anaphylactic reactions, hypersensitivity, hypoglycemia and hyperkalemia, depression, anxiety, insomnia, syncope, blurred vision, drowsiness.